Background Metabolic syndrome (MS) is a cluster of metabolic abnormalities, which has
been regarded as a pivotal risk factor for cardiovascular diseases. Recent studies focusing …

The aim of this study was to analyze the impact of metabolic syndrome (MetS) on outcome of
patients with localized renal cell carcinoma (RCC). A retrospective database was compiled …

Background Metabolic syndrome (MetS) has been related to increased risks of a variety of
cancers. However, the association between MetS and the risk of renal cell cancer (RCC) …

Objective: This study analyzes risk associations between metabolic syndrome (MetS)
components and the extent and prognosis of renal cell cancer (RCC). The independent …

Purpose To determine whether individual and/or cumulative components of metabolic
syndrome (obesity, hypertension, dyslipidemia, and hyperglycemia) are associated with …

Purpose: Renal cell carcinoma (RCC) is increasingly being recognized as a metabolic
disease in recent studies. The aim of the present study was to identify the prevalence of …

BACKGROUND: The worldwide prevalence of metabolic syndrome is increasing and has
been associated with chronic kidney disease. Kidney pathological findings in patients with …

Accepted: 10 November 2016/Published online: 18 November 2016© Springer-Verlag
Berlin Heidelberg 2016 dependent variable on univariable analysis (P value< 0.2) are …

Purpose Nephrectomy, partial or radical, remains the standard treatment for renal cell
carcinoma (RCC). However, increased risk of chronic kidney disease (CKD) must still be …

Background More and more evidences show that metabolic syndrome (MS) is closely
related to clear cell renal cell carcinoma (ccRCC), but the impact of MS on Fuhrman grade …